Last reviewed · How we verify
placebo to dexamethasone
placebo to dexamethasone is a Corticosteroid Small molecule drug developed by Aswan University Hospital. It is currently in Phase 3 development for Malignant neoplasm of brain and central nervous system, Malignant neoplasm of eye and adnexa. Also known as: Placebo.
Dexamethasone is a synthetic corticosteroid with anti-inflammatory and immunosuppressive properties.
Dexamethasone is a synthetic corticosteroid with anti-inflammatory and immunosuppressive properties. Used for Malignant neoplasm of brain and central nervous system, Malignant neoplasm of eye and adnexa.
At a glance
| Generic name | placebo to dexamethasone |
|---|---|
| Also known as | Placebo |
| Sponsor | Aswan University Hospital |
| Drug class | Corticosteroid |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 3 |
Mechanism of action
It works by inhibiting the production of pro-inflammatory cytokines and inducing the production of anti-inflammatory cytokines. This leads to a reduction in inflammation and immune response.
Approved indications
- Malignant neoplasm of brain and central nervous system
- Malignant neoplasm of eye and adnexa
Common side effects
- Nausea
- Vomiting
- Headache
- Dizziness
- Insomnia
Key clinical trials
- Management of Pain in Lumbar Arthrodesis (PHASE4)
- Soaked Pharyngeal Packing Agents in Septoplasty (PHASE3)
- A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer (PHASE2)
- Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia (PHASE2)
- Erector Spinae Plane Block for Acute Low Back Pain (NA)
- A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES) (PHASE3)
- A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES) (PHASE3)
- Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- placebo to dexamethasone CI brief — competitive landscape report
- placebo to dexamethasone updates RSS · CI watch RSS
- Aswan University Hospital portfolio CI
Frequently asked questions about placebo to dexamethasone
What is placebo to dexamethasone?
How does placebo to dexamethasone work?
What is placebo to dexamethasone used for?
Who makes placebo to dexamethasone?
Is placebo to dexamethasone also known as anything else?
What drug class is placebo to dexamethasone in?
What development phase is placebo to dexamethasone in?
What are the side effects of placebo to dexamethasone?
Related
- Drug class: All Corticosteroid drugs
- Manufacturer: Aswan University Hospital — full pipeline
- Therapeutic area: All drugs in Oncology
- Indication: Drugs for Malignant neoplasm of brain and central nervous system
- Indication: Drugs for Malignant neoplasm of eye and adnexa
- Also known as: Placebo
- Compare: placebo to dexamethasone vs similar drugs
- Pricing: placebo to dexamethasone cost, discount & access